Recombinant soluble human CD4 April 12, 2017 Recombinant soluble human CD4 Trade Name Receptin Orphan Indication Acquired immunodeficiency syndrome USA Market Approval USA USA Designation Date 1989-11-20 00:00:00 Sponsor Biogen, Inc.;14 Cambridge Center;Cambridge, Massachusetts, 02142